Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Endocrinology

Is Prolactinoma Genetic? MEN1, AIP & Hereditary Risk

At a Glance

Most prolactinomas are sporadic and not inherited. However, a rare percentage are hereditary and linked to MEN1 or AIP genetic mutations. Genetic testing is usually only recommended if you were diagnosed before age 30, have a strong family history of endocrine tumors, or have an unusually large tumor.

If you have recently been diagnosed with a prolactinoma, it is completely natural to wonder if you might pass this condition on to your children. The reassuring news is that the vast majority of prolactinomas are sporadic, meaning they happen by chance and are not inherited [1][2]. Most people with a prolactinoma do not have a genetic mutation that caused their tumor, and the risk of their children developing one is very low [3][2].

However, a small percentage of prolactinomas are hereditary and linked to specific genetic mutations [1][2]. In these rare cases, the tumor is usually part of a broader genetic syndrome.

When a prolactinoma is hereditary, it is most often associated with one of two specific genetic conditions [4][5]:

  • Multiple Endocrine Neoplasia type 1 (MEN1): This inherited disorder causes tumors to form in the endocrine glands, most commonly the pituitary gland, parathyroid glands, and the pancreas [4][6]. If a prolactinoma is caused by an MEN1 mutation, the patient or their family members will typically have a history of other endocrine issues [7][1].
  • Familial Isolated Pituitary Adenoma (FIPA) and AIP Mutations: Some families have a history of pituitary tumors without other endocrine problems, a condition known as FIPA [4][5]. Many of these cases are linked to a mutation in the AIP gene (Aryl hydrocarbon receptor-interacting protein) [7][6]. Prolactinomas associated with AIP mutations tend to appear in young people and can sometimes grow larger or be more aggressive than sporadic tumors [8][9].

It is important to know that inheriting a genetic mutation does not guarantee that your child will develop a tumor [1][5]. It simply means they have a higher risk compared to the general population, which allows doctors to monitor them proactively and catch any potential issues early.

Should My Children Be Tested?

Because true hereditary prolactinomas are rare, routine genetic testing of children or family members is not recommended for most patients [3][2]. If you were over the age of 30 when diagnosed, have a standard-sized tumor that responds well to medication, and have no family history of similar issues, the likelihood of a genetic link is extremely low [2].

However, your doctor may recommend testing if you meet certain “red flags” that suggest a higher chance of an underlying genetic mutation [9][7][1]:

  • Young age at diagnosis: You were diagnosed with a prolactinoma or another pituitary tumor before the age of 30, and particularly if diagnosed during childhood or adolescence [9][7][1].
  • Strong family history: You have blood relatives who have had pituitary tumors, pancreatic tumors, or hyperparathyroidism (overactive glands in the neck that cause high calcium levels and frequent kidney stones) [7][8][1].
  • Unusual tumor characteristics: Your tumor is a giant prolactinoma (typically defined as larger than 4 centimeters or 1.5 inches) or is highly resistant to standard medical treatments [7][8][1].

The Testing Process

If you meet any of these criteria, the first step is usually to test you (with a simple blood test) for mutations in genes like AIP or MEN1, rather than testing your children right away [9][7]. This process is best done with a genetic counselor who can help you understand the risks, benefits, and meaning of the results for your family [1][5].

If a mutation is found, your care team will help you determine if and when your children should be screened [1][5]. Screening for children often starts with simple, non-invasive steps like tracking their height and growth patterns or doing basic blood tests to check hormone levels, rather than jumping straight to MRI scans.

Common questions in this guide

Is prolactinoma hereditary?
The vast majority of prolactinomas happen by chance and are not inherited. However, a small percentage are hereditary and can be linked to specific genetic syndromes like MEN1 or FIPA.
Should my children get genetic testing for prolactinoma?
Routine genetic testing for children is not typically recommended because hereditary prolactinomas are rare. If your doctor suspects a genetic link based on your family history or age, they will usually test your blood first before screening your children.
What are the signs that a prolactinoma might be genetic?
Red flags for a genetic link include being diagnosed before age 30, having a very large or treatment-resistant tumor, or having a family history of pituitary tumors, pancreatic tumors, or overactive parathyroid glands.
What is MEN1 and how does it relate to prolactinoma?
Multiple Endocrine Neoplasia type 1 (MEN1) is an inherited disorder that causes tumors in several endocrine glands. In rare cases, a prolactinoma can be caused by an MEN1 mutation, which is usually accompanied by a family history of other endocrine issues like kidney stones or high calcium levels.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my age at diagnosis and the size of my tumor, do you recommend I undergo genetic testing for MEN1 or AIP mutations?
  2. 2.Given my personal and family medical history, what is the likelihood that my prolactinoma is hereditary?
  3. 3.If genetic testing is appropriate, can you refer me to a genetic counselor to help interpret the results and what they mean for my family?
  4. 4.Are there any specific symptoms, growth patterns, or health issues I should look out for in my children as they grow up?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    AIP variant causing familial prolactinoma.

    Carty DM, Harte R, Drummond RS, et al.

    Pituitary 2021; (24(1)):48-52 doi:10.1007/s11102-020-01085-5.

    PMID: 33010004
  2. 2

    Genetic testing in prolactinomas: a cohort study.

    Boukerrouni A, Cuny T, Anjou T, et al.

    European journal of endocrinology 2023; (189(6)):567-574 doi:10.1093/ejendo/lvad148.

    PMID: 37956455
  3. 3

    AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center.

    Daly AF, Cano DA, Venegas-Moreno E, et al.

    Endocrine connections 2019; (8(4)):338-348.

    PMID: 30822274
  4. 4

    [Tumor predisposition in endocrinology - from MEN to FIPA].

    Jegodzinski L, Gebauer J

    Deutsche medizinische Wochenschrift (1946) 2024; (149(6)):283-289 doi:10.1055/a-2131-2450.

    PMID: 38412983
  5. 5

    Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.

    Miranda ISM, Valadares LP, Barra GB, et al.

    Frontiers in endocrinology 2023; (14()):1117873 doi:10.3389/fendo.2023.1117873.

    PMID: 36967793
  6. 6

    Pituitary gigantism: a case series from Hospital de San José (Bogotá, Colombia).

    García WR, Cortes HT, Romero AF

    Archives of endocrinology and metabolism 2019; (63(4)):385-393 doi:10.20945/2359-3997000000150.

    PMID: 31365626
  7. 7

    Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1.

    Gan HW, Bulwer C, Jeelani O, et al.

    International journal of pediatric endocrinology 2015; (2015(1)):15 doi:10.1186/s13633-015-0011-5.

    PMID: 26180530
  8. 8

    AIP mutations and gigantism.

    Rostomyan L, Potorac I, Beckers P, et al.

    Annales d'endocrinologie 2017; (78(2)):123-130 doi:10.1016/j.ando.2017.04.012.

    PMID: 28483363
  9. 9

    Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.

    Korbonits M, Blair JC, Boguslawska A, et al.

    Nature reviews. Endocrinology 2024; (20(5)):278-289 doi:10.1038/s41574-023-00948-8.

    PMID: 38336897

This information about prolactinoma genetics is for educational purposes only and does not replace professional medical advice. Always discuss genetic testing and family risks with your endocrinologist or a genetic counselor.

Get notified when new evidence is published on Prolactinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.